Informing Precision Medicine.

Imagine diagnosing cancer, even what specific type of cancer, non-invasively.  This is especially important in the Lung, where biopsies and surgeries have high morbidity and mortality rates. RevealDx is a Seattle-based software company whose mission is dramatically improve lung cancer outcomes using non-invasive diagnosis. We are delivering the most advanced, radiomics and AI-enabled, lung cancer decision support software in the world. Click below to learn more.

Actionable Radiomic Insights

Clinicians can be confident that their performance will be better if they include mSI in their assessment.

Single Click Operation

A single click is all that is needed to compute the mSI, and the results are displayed within a few seconds.

Significant Cost Savings

Cost can be dramatically decreased by reducing unnecessary procedures.

Latest News

RevealDx and Riverain Technologies Partner to Improve Lung Cancer Detection with mSI Malignancy Scoring

10.03.2024

Seattle, WA and Miamisburg, OH – October 3, 2024 – RevealDx and Riverain Technologies, leaders in the detection and characterization of lung nodules, announced the integration of their products, as well as distribution by Riverain in Canada. Both companies will be exhibiting at the CHEST Meeting beginning October 7, 2024. The RevealDX technology characterizes nodules RevealDx and Riverain Technologies Partner to Improve Lung Cancer Detection with mSI Malignancy Scoring

[ MORE ]

Listen to the Skeleton Crew Interview our CEO Chris Wood

10.17.2023

Here’s the link to the episode: https://x-raytechnicianschools.com/lung-cancer-detection/

[ MORE ]